Search from the table of contents of 2.5 million books
Advanced Search (Beta)
Home > Cancer Immunotherapy: Paradigms, Practice and Promise > Targeted Toxins in Cancer Immunotherapy
Cancer Immunotherapy: Paradigms, Practice and Promise |
Tyler J. Curiel
Springer New York
Cancer Immunotherapy: Paradigms, Practice and Promise
Targeted Toxins in Cancer Immunotherapy
Authors

Devalingam Mahalingam; Michael J. Brumlik; Reinhard Waehler; David T. Curiel; Tyler J. Curiel

ARI Id

1664441067965_1696015

Access

Not Available Free

Pages

377-396

DOI

10.1007/978-1-4614-4732-0_12

Chapter URL

https://rd.springer.com/chapter/10.1007/978-1-4614-4732-0_12

Table of Contents of Book
Showing 1 to 20 of 21 entries
Chapters/HeadingsAuthor(s)PagesInfo
Front Matter
i-ix
Front Matter
1-1
Historical Perspectives and Current Trends in Cancer Immunotherapy
Tyler J. Curiel
3-15
T Cell and Antigen-Presenting Cell Subsets in the Tumor Microenvironment
Cailin Moira Wilke; Shuang Wei; Lin Wang; Ilona Kryczek; Jingyuan Fang; Guobin Wang et al.
17-44
Front Matter
45-45
Adoptive T Cell Transfer
Donald R. Shaffer; Conrad Russell Y. Cruz; Cliona M. Rooney
47-70
Dendritic Cell-Based Cancer Immunotherapy: Achievements and Novel Concepts
K. F. Bol; G. Schreibelt; E. H. J. G. Aarntzen; I. J. M. de Vries; C. G. Figdor
71-108
Front Matter
109-109
Peptide and Protein-Based Cancer Vaccines
Marion Braun; Rachel Perret; Godehard Scholz; Pedro Romero
111-146
Antigen Targeting to Dendritic Cells for Cancer Immunotherapy
Dinja Oosterhoff; David T. Curiel; Tanja D. de Gruijl
147-171
Cytokines in the Treatment of Cancer
Kim Margolin; Mark Lazarus; Howard L. Kaufman
173-210
Immune Co-signaling to Treat Cancer
Margaret K. Callahan; Jedd D. Wolchok; James P. Allison; Padmanee Sharma
211-280
Managing Regulatory T Cells to Improve Cancer Immunotherapy
Tyler J. Curiel
281-314
Myeloid-Derived Suppressor Cells in Cancer: Mechanisms and Therapeutic Perspectives
Paulo C. Rodríguez; Augusto C. Ochoa
315-333
Antibodies as Cancer Immunotherapy
Devalingam Mahalingam; Tyler J. Curiel
335-376
Targeted Toxins in Cancer Immunotherapy
Devalingam Mahalingam; Michael J. Brumlik; Reinhard Waehler; David T. Curiel; Tyler J. Curiel
377-396
Front Matter
397-397
Miscellaneous Approaches and Considerations: TLR Agonists and Other Inflammatory Agents, Anti-Chemokine Agents, Infectious Agents, Tumor Stroma Targeting, Age and Sex Effects, and Miscellaneous Small Molecules
Robert S. Svatek; Tyler J. Curiel
399-424
Monitoring Antigen-Specific Responses in Clinical Trials of Cancer Immunotherapy
Aude G. Chapuis; Cassian Yee
425-453
Issues in Pre-clinical Models, Clinical Trial Design and Analytical Considerations in Developing and Evaluating Novel Cancer Immunotherapies
Marijo Bilusic; Ravi A. Madan; James L. Gulley
455-474
Chapters/HeadingsAuthor(s)PagesInfo
Showing 1 to 20 of 21 entries
Similar Books
Similar Chapters
Similar Thesis

Similar News

Similar Articles
Similar Article Headings